- ECONOMIC IMPACT -

Latest update: 18 November 

Many economists have cut their GDP forecasts. The 2020 consensus forecast for GDP growth is currently negative and many predict a recession.

The unemployment rate in South Africa reached a 17-year high of 30.8% in Q3 2020 as people started looking for jobs following the easing of coronavirus restrictions.

-4.4%

The IMF has revised its 2020 global GDP forecast to -4.4% from an estimate of -4.9% made in June.

$11tn

Over the next two years, the global economy will experience a cumulative loss of approximately $11tn according to GlobalData.

Impact of Covid-19 on equity indices

- SECTOR IMPACT: MEDICAL DEVICES -

Latest update: 02 December 

financial impact and reflief

$100bn

The US Congress appropriated $100bn in the Coronavirus Aid, Relief and Economic Security (CARES) Act (PL 116-136) and $75bn through the Paycheck Protection Program and Health Care Enhancement Act (PL 116-139) for healthcare providers.

25.5%

3M announced that its Q3 healthcare sales rose 25.5% year-on-year, likely due to increased demand because of the backlog of procedures during Covid-19 lockdowns.

wearable device market impact 

Wearables are proven to be a great source of monitoring, collecting, and predicting Covid-19 symptoms without having a face-to-face appointment with a patient.


Wearables could include a variety of health trackers, including electrocardiogram, skin temperature, and electrodermal activity sensors that allow them to track various health-related statistics in real time.


This viable information can then be sent via the internet to a patient’s primary physician, keeping them informed and able to make accurate decisions about treatment without seeing the patient in person.


Although  wearable tech was previously avoided by consumers due to high prices, rapid technological innovation has enabled a decline in prices, making wearables more attractive to average consumers. Therefore, consumers may be more willing to use remote patient care with wearable tech now than prior to the pandemic.

Key Medical device market developments

Cardiovascular devices

All cardiovascular markets were negatively affected by Covid-19, which caused the postponement of non-urgent surgical procedures, contributing to a seven-month decline in sales and procedure volumes.


According to GlobalData’s SKU database, September marked the first month where cardiovascular device sales in the US surpassed revenues achieved in January, and monthly revenue tracking is now trending on a 2.1% growth rate for 2020.


In vitro diagnostics devices 

Financial statements for Q3 2020 have been released for many major In vitro diagnostics companies and show strong revenue growth due to Covid-19 testing.


While most non-Covid-19 related diagnostic segments are still down, many companies are reporting only single-digit declines, indicating a recovery of these segments since the pandemic started. 


General surgery devices

During Q3 2020, sales for general surgery devices had risen to between 80% and 90% of what was reported during the same time period in 2019. In Q4 2020, GlobalData expects revenue for most general surgery device markets to return to pre-Covid-19 levels.

Share this article

Go to article: Home | Becoming the first human cyborgGo to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: uvexGo to article: BriefingGo to article: Industry newsGo to article: Covid-19 executive briefing by GlobalDataGo to article: The medical industry briefingGo to article: Industrial Indexing Systems Company InsightGo to article: Industrial Indexing SystemsGo to article: ElectroCraftGo to article: KSP Go to article: Electronic Sensor TechnologyGo to article: CommentGo to article: Robotics in medtech industry primed for significant growth to end bumpy 2020Go to article: AI-powered platforms expand further into traditional healthcareGo to article: Penumbra’s Indigo Aspiration System expected to continue dominating US marketGo to article: Early on, 5G is already making an impact and demonstrating its potentialGo to article: ENT market on course for full recovery following year disrupted by Covid-19Go to article: Research Collective Company Insight Go to article: Research CollectiveGo to article: Repsol Go to article: SartoriusGo to article: Peak Performance Compounding Go to article: In DepthGo to article: The ins and outs of the SABA asthma inhalerGo to article: Can you hear me now? The tech transforming clinical communicationGo to article: Should biobanks release diagnostic data to patients?Go to article: Inside the mission to become the first cyborgGo to article: Miracle metal: could copper clothing help fight infection?Go to article: LexaGene’s new automated testing platformGo to article: Recurrent fainting: could a new pacemaker provide a solution?Go to article: Kickstarting AI and smart data in resource-limited health systemsGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: Sandvik Company InsightGo to article: Sandvik Go to article: ICF MercantileGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The medical industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: Fisba Go to article: INDO-MIMGo to article: AccumoldGo to article: GS SwissGo to article: oncgnosticsGo to article: EventsGo to article: Next issueGo to article: CODIXX Go to article: Alicona ImagingGo to article: RETERO Go to article: CoherentGo to article: Eastprint Incorporated